101 related articles for article (PubMed ID: 2824082)
21. Co-expression and amplification of dihydrofolate reductase cDNA and the Escherichia coli XGPRT gene in Chinese hamster ovary cells.
Ringold G; Dieckmann B; Lee F
J Mol Appl Genet; 1981; 1(3):165-75. PubMed ID: 6180118
[TBL] [Abstract][Full Text] [Related]
22. Selective amplification in methotrexate-resistant mouse cells of an artificial dihydrofolate reductase transcription unit making use of cryptic splicing and polyadenylation sites.
Breathnach R
EMBO J; 1984 Apr; 3(4):901-8. PubMed ID: 6202514
[TBL] [Abstract][Full Text] [Related]
23. Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer cells.
Morales C; García MJ; Ribas M; Miró R; Muñoz M; Caldas C; Peinado MA
Mol Cancer Ther; 2009 Feb; 8(2):424-32. PubMed ID: 19190117
[TBL] [Abstract][Full Text] [Related]
24. Amplification and organization of dihydrofolate reductase genes in a human leukemic cell line, K-562, resistant to methotrexate.
Srimatkandada S; Medina WD; Cashmore AR; Whyte W; Engel D; Moroson BA; Franco CT; Dube SK; Bertino JR
Biochemistry; 1983 Dec; 22(25):5774-81. PubMed ID: 6661412
[TBL] [Abstract][Full Text] [Related]
25. X-ray induction of methotrexate resistance due to dhfr gene amplification.
Hahn P; Nevaldine B; Morgan WF
Somat Cell Mol Genet; 1990 Sep; 16(5):413-23. PubMed ID: 2122527
[TBL] [Abstract][Full Text] [Related]
26. Role of the locus and of the resistance gene on gene amplification frequency in methotrexate resistant Leishmania tarentolae.
Kündig C; Leblanc E; Papadopoulou B; Ouellette M
Nucleic Acids Res; 1999 Sep; 27(18):3653-9. PubMed ID: 10471733
[TBL] [Abstract][Full Text] [Related]
27. A new myeloblastic leukemia cell line with double minute chromosomes. Induction of methotrexate resistance and dihydrofolate reductase gene amplification.
Saito H; Kishi K; Narita M; Furukawa T; Nagura E; Maekawa T; Abe T; Shibata A
Leuk Res; 1992; 16(3):217-26. PubMed ID: 1560671
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of methotrexate-sensitivity of choriocarcinoma cells in culture.
Inoue T; Nagura E; Toyoda T; Ishizuka T; Gotoh S; Kawashima K; Tomoda Y; Nagai Y
Jpn J Cancer Res; 1988 Mar; 79(3):400-5. PubMed ID: 2836349
[TBL] [Abstract][Full Text] [Related]
29. Cytologic evidence for gene amplification in methotrexate-resistant cells obtained from a patient with ovarian adenocarcinoma.
Trent JM; Buick RN; Olson S; Horns RC; Schimke RT
J Clin Oncol; 1984 Jan; 2(1):8-15. PubMed ID: 6699660
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic resistance to methotrexate and N-phosphonacetyl L-aspartate is induced by treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA).
Kinsella AR; Fox M
Int J Cancer; 1988 Jul; 42(1):87-93. PubMed ID: 3391708
[TBL] [Abstract][Full Text] [Related]
31. Effects of estrogen and tamoxifen on the regulation of dihydrofolate reductase gene expression in a human breast cancer cell line.
Levine RM; Rubalcaba E; Lippman ME; Cowan KH
Cancer Res; 1985 Apr; 45(4):1644-50. PubMed ID: 3978632
[TBL] [Abstract][Full Text] [Related]
32. Development of methotrexate resistance in a human squamous cell carcinoma of the head and neck in culture.
Frei E; Rosowsky A; Wright JE; Cucchi CA; Lippke JA; Ervin TJ; Jolivet J; Haseltine WA
Proc Natl Acad Sci U S A; 1984 May; 81(9):2873-7. PubMed ID: 6201865
[TBL] [Abstract][Full Text] [Related]
33. Analysis of dihydrofolate reductase gene amplification in a methotrexate-resistant human tumor cell line.
Meltzer PS; Cheng YC; Trent JM
Cancer Genet Cytogenet; 1985 Aug; 17(4):289-300. PubMed ID: 4016714
[TBL] [Abstract][Full Text] [Related]
34. [Methotrexate and its drug resistance].
Nagura E
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2882-7. PubMed ID: 3178237
[TBL] [Abstract][Full Text] [Related]
35. Selection for methotrexate resistance in mammalian cells bearing a Drosophila dihydrofolate reductase transgene: Methotrexate resistance in transgenic mammalian cells.
Affleck JG; Nowickyj SM; Walker VK
Cell Biol Toxicol; 2010 Apr; 26(2):117-26. PubMed ID: 19337845
[TBL] [Abstract][Full Text] [Related]
36. Molecular mechanisms of resistance to antifolates, a review.
Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR
Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336
[TBL] [Abstract][Full Text] [Related]
37. Characterization of chimeric antibody producing CHO cells in the course of dihydrofolate reductase-mediated gene amplification and their stability in the absence of selective pressure.
Kim SJ; Kim NS; Ryu CJ; Hong HJ; Lee GM
Biotechnol Bioeng; 1998 Apr; 58(1):73-84. PubMed ID: 10099263
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic heterogeneity in cultured human head and neck squamous cell carcinoma lines with low-level methotrexate resistance.
Rosowsky A; Wright JE; Cucchi CA; Lippke JA; Tantravahi R; Ervin TJ; Frei E
Cancer Res; 1985 Dec; 45(12 Pt 1):6205-12. PubMed ID: 2415240
[TBL] [Abstract][Full Text] [Related]
39. Retinoic-acid-induced differentiation prevents gene amplification in teratocarcinoma stem cells.
Lücke-Huhle C; Herrlich P
Int J Cancer; 1991 Feb; 47(3):461-5. PubMed ID: 1993556
[TBL] [Abstract][Full Text] [Related]
40. Increase of dihydrofolate reductase in peripheral blood lymphocytes of rheumatoid arthritis patients treated with low-dose oral methotrexate.
Rodenhuis S; Kremer JM; Bertino JR
Arthritis Rheum; 1987 Apr; 30(4):369-74. PubMed ID: 3580007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
